Patents by Inventor Kunal Ray

Kunal Ray has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140302042
    Abstract: A set of biomarkers (e.g., genes and gene products) that can accurately inform about the risk of cancer progression and recurrence, as well as methods of their use are disclosed.
    Type: Application
    Filed: June 29, 2012
    Publication date: October 9, 2014
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Lynda Chin, Kenneth L. Scott, Papia Ghosh, Kunal Rai, Chengyin Min
  • Publication number: 20110318738
    Abstract: Disclosed herein are methods and systems directed at detecting, evaluating, ameliorating, preventing and treating an oncogenic event. The disclosed methods and systems can comprise one or more Demethylase System Components or other compositions that can be used alone or in combination to detect, evaluate, treat, ameliorate, or prevent an oncogenic event.
    Type: Application
    Filed: December 4, 2009
    Publication date: December 29, 2011
    Applicant: University of Utah Research Foundation
    Inventors: David Jones, Bradley Cairns, Kunal Rai
  • Patent number: 6428958
    Abstract: The present invention relates to an isolated nucleic acid molecule encoding canine RPE65. The present invention also relates to an isolated nucleic acid molecule encoding canine RPE65 having a mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness. The present invention also relates to a method for identifying dogs which are genetically normal, are carriers of, or are affected with congenital stationary night blindness, said method including obtaining a biological sample from a dog and testing the biological sample for a gene encoding canine RPE65 having a nucleic acid mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness. Another aspect of the present invention relates to a method for selecting dogs for breeding.
    Type: Grant
    Filed: August 24, 2000
    Date of Patent: August 6, 2002
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Gustavo D. Aguirre, Gregory M. Acland, Kunal Ray
  • Patent number: 6201114
    Abstract: The present invention relates to an isolated nucleic acid molecule encoding canine RPE65. The present invention also relates to an isolated nucleic acid molecule encoding canine RPE65 having a mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness. The present invention also relates to a method for identifying dogs which are genetically normal are carriers of, or are affected with congenital stationary night blindness, said method including obtaining a biological sample from a dog and testing the biological sample for a gene encoding canine RPE65 having a nucleic acid mutation in one or both alleles indicative of a carrier of or a dog affected with congenital stationary night blindness. Another aspect of the present invention relates to a method for selecting dogs for breeding.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: March 13, 2001
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Gustavo D. Aguirre, Gregory M. Acland, Kunal Ray
  • Patent number: 5804388
    Abstract: Provided are nucleic acid molecules which comprise at least a portion of a polymorphic genetic marker for determining whether a canine has a mutated progressive rod-cone degeneration disease (prcd) gene locus in one or both alleles. The genetic markers are located on canine chromosome 9 in a genomic region identified as the prcd-informative region. A method for making genetic markers representing polymorphic sequences located in the prcd-informative region of canine chromosome 9 comprises isolating a polymorphic DNA sequence in the prcd-informative region, using oligonucleotides complementary with at least a portion of the sequence to amplify the sequence, and analyzing canine chromosome 9 in a prcd-informative pedigree for the ability of the polymorphic sequence to co-segregate with the prcd gene locus by a linkage test.
    Type: Grant
    Filed: July 10, 1997
    Date of Patent: September 8, 1998
    Assignee: Cornell Research Foundation, Inc.
    Inventors: Gustavo Aguirre, Gregory Acland, Kunal Ray